Gadolinium- or iodine-based contrast media: which choice?

Pollack HM History of iodinated contrast media. In: Thomsen HS Muller RN Mattrey RF (eds). Trends in Contrast Media , Heidelberg: Springer Verlag, 1999, pp. 3–20.

Caravan P Ellison JJ McMurry TJ . Gadolinium (III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chemical Reviews 1999; 99: 2293–2352.

Grobner T . Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104–1108.

Marckmann P Skov L Rossen K . Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359–2362.

COMMISSION DECISION of 1.7.2010 concerning, in the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations for Gadolinium-containing contrast agents for human use which contain one or more of the active substances “gadodiamide, gadopentetic acid, gadobenic acid, gadoxetic acid, gadoteridol, gadobutrol and gadoteric acid”. See http://www.esur.org/fileadmin/content/NSF/NSF_Referral-EC_Decision-Annexes-en_July_2010.pdf (accessed April 2014).

Thomsen HS Leander P Radiography with gadolinium-based contrast media. In: Thomsen HS Webb JAW (eds). Contrast Media: Safety Issues and ESUR Guidelines , Heidelberg: Springer Verlag, 2014, pp. 193–200.

Elmstahl B Nyman U Leander P . Gadolinium contrast media are more nephrotoxic than low dose iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs. Acad Radiol 2004; 11: 1219–1228.

Newhouse JH RoyChoudhury A . Quantitating contrast medium-induced nephropathy: controlling the controls. Radiology 2013; 267: 4–8.

McDonald JS McDonald RJ Comin J . Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 2013; 267: 119–128.

Stacul F van der Molen AJ Reimer P . on behalf of the Contrast Media Safety Committee of the European Society of Urogenital Radiology. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21: 2527–2541.

Davenport MS Khalatbari S Cohan RH . Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: Risk stratification by using estimated glomerular filtration rate. Radiology 2013; 268: 719–728.

Thomsen HS Stacul F Webb JAW Contrast medium-induced nephropathy. In: Thomsen HS Webb JAW (eds). Contrast Media: Safety Issues and ESUR Guidelines, Heidelberg: Springer Verlag, 2014, pp. 81–104.

Cowper SE Robin HS Steinberg SM . Scleromyxoedema-like cutaneous disease in renal dialysis patients. Lancet 2000; 356: 1000–1001.

Thomsen HS Nephrogenic systemic fibrosis and gadolinium-based contrast media. In: Thomsen HS Webb JAW (eds). Contrast Media: Safety Issues and ESUR Guidelines , Heidelberg: Springer Verlag, 2014, pp. 207–218.

Pirovano G Munley J Schultz C . Nephrogenic systemic fibrosis: a review of published cases and results from three prospective observational studies. ECR 2012 Book of Abstracts. Insights Imaging 2012; 3(Suppl. 1): S293.

Thomsen HS Morcos SK Almén T . Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2013; 23: 307–318.

Clement O Webb JAW Acute adverse reactions to contrast media: mechanisms and prevention. In: Thomsen HS Webb JAW (eds). Contrast Media: Safety Issues and ESUR Guidelines , Heidelberg: Springer Verlag, 2014, pp. 51–60.

Azzouz M Rømsing J Thomsen HS . Acute non-renal adverse events after unenhanced and enhanced CT and MR. Open J Clin Diagn 2013; 3: 85–93.

Thomsen HS Webb JAW . The Lalli and Weber effects and the incidence of acute non-renal adverse reactions to contrast media. Acta Radiol 2012; 53: 953–954.

Dawson P Punwani S . Nephrogenic systemic fibrosis: non-gadolinium options for the imaging of CKD/ESRD patients. Semin Dial 2008; 21: 160–165.